On November 7, 2019, Pfizer Inc., a US pharmaceutical company, stated in a filing with the US Securities and Exchange Commission that in June 2019 it had received an informal request from the FCPA unit of the US Department of Justice, seeking information relating to the Company’s operations in Russia. Pfizer stated that it had received a similar informal request from the SEC’s FCPA unit in September 2019. Pfizer stated that it is producing records pursuant to these requests.
November 7, 2019
US pharmaceutical company under investigation by DOJ, SEC
Related by Topic
September 8, 2023 News Alert
Connecticut oil and gas trader charged with FCPA violations for allegedly bribing Petrobras officials
September 4, 2023 News Alert
September 3, 2023 News Alert